A systematic review of the evidence on the treatment of rapid cycling bipolar disorder

Bipolar Disorders

Volumn 15, Issue 2, 2013, Pages 115-137

  Fountoulakis, Konstantinos N ^a   Kontis, Dimitrios ^b   Gonda, Xenia ^c   Yatham, Lakshmi N ^d  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Psychiatric Hospital of Attika Dafni   (Greece)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bipolar; Randomized; Rapid cycling; Review; Treatment

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; ESCITALOPRAM; ICOSAPENTAENOIC ACID ETHYL ESTER; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM; MELATONIN; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; SERTRALINE; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

BIPOLAR DISORDER; BIPOLAR II DISORDER; CLINICAL PROTOCOL; CONSENSUS; DEPRESSION; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; MAJOR DEPRESSION; META ANALYSIS; MONOTHERAPY; MOOD DISORDER; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAPID CYCLING BIPOLAR DISORDER; RELAPSE; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; HUMANS; MEDLINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT OUTCOME;

EID: 84874261431     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12045     Document Type: Review

References (52)

1. American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th edn. Washington, DC: American Psychiatric Association, 2000.
2. Dunner DL, Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229-233.
3. Kupka RW, Luckenbaugh DA, Post RM, Leverich GS, Nolen WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry 2003; 64: 1483-1494.
4. Kupka RW, Luckenbaugh DA, Post RM et al.Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005; 162: 1273-1280.
5. Schneck CD, Miklowitz DJ, Calabrese JR et al.Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry 2004; 161: 1902-1908.
6. Coryell W, Solomon D, Turvey C et al.The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003; 60: 914-920.
7. Koukopoulos A, Sani G, Koukopoulos AE et al.Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. J Affect Disord 2003; 73: 75-85.
8. Calabrese JR, Rapport DJ, Youngstrom EA, Jackson K, Bilali S, Findling RL. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry 2005; 20: 92-95.
9. Schneck CD. Treatment of rapid-cycling bipolar disorder. J Clin Psychiatry 2006; 67 (Suppl. 11): 22-27.
10. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980; 13: 156-167.
11. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179-184.
12. Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49: 126-131.
13. Extein IL. High doses of levothyroxine for refractory rapid cycling. Am J Psychiatry 2000; 157: 1704-1705.
14. Afflelou S, Auriacombe M, Cazenave M, Chartres JP, Tignol J. [Administration of high dose levothyroxine in treatment of rapid cycling bipolar disorders. Review of the literature and initial therapeutic application apropos of 6 cases]. Encephale 1997; 23: 209-217.
15. Leibenluft E, Feldman-Naim S, Turner EH, Wehr TA, Rosenthal NE. Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder. J Clin Psychiatry 1997; 58: 383-388.
16. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990; 47: 435-440.
17. Amsterdam JD, Wang CH, Shwarz M, Shults J. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. J Affect Disord 2009; 112: 219-230.
18. Baldessarini RJ, Hennen J, Wilson M et al.Olanzapine versus placebo in acute mania: treatment responses in subgroups. J Clin Psychopharmacol 2003; 23: 370-376.
19. Vieta E, Calabrese JR, Hennen J et al.Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry 2004; 65: 1420-1428.
20. Shi L, Schuh LM, Trzepacz PT, Huang LX, Namjoshi MA, Tohen M. Improvement of Positive and Negative Syndrome Scale cognitive score associated with olanzapine treatment of acute mania. Curr Med Res Opin 2004; 20: 1371-1376.
21. Suppes T, Brown E, Schuh LM, Baker RW, Tohen M. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. J Affect Disord 2005; 89: 69-77.
22. Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord 2010; 121: 106-115.
23. Suppes T, Marangell LB, Bernstein IH et al.A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 2008; 111: 334-343.
24. Post RM, Altshuler LL, Leverich GS et al.Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006; 189: 124-131.
25. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 1997; 58: 470-478.
26. Ghaemi SN, Ostacher MM, El-Mallakh RS et al.Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J Clin Psychiatry 2010; 71: 372-380.
27. Tondo L, Hennen J, Baldessarini RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand 2003; 108: 4-14.
28. Parker G, Tully L, Olley A, Hadzi-Pavlovic D. SSRIs as mood stabilizers for bipolar II disorder? A proof of concept study. J Affect Disord 2006; 92: 205-214.
29. Suppes T, Eudicone J, McQuade R, Pikalov A III, Carlson B. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. J Affect Disord 2008; 107: 145-154.
30. Tohen M, Sanger TM, McElroy SL et al.Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999; 156: 702-709.
31. Sanger TM, Tohen M, Vieta E et al.Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord 2003; 73: 155-161.
32. Tohen M, Jacobs TG, Grundy SL et al.Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000; 57: 841-849.
33. Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2007; 9: 413-425.
34. Muzina DJ, Gao K, Kemp DE et al.Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 2011; 72: 813-819.
35. Wang Z, Gao K, Kemp DE et al.Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study. Psychopharmacol Bull 2010; 43: 5-21.
36. Keck PE Jr, Mintz J, McElroy SL et al.Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 2006; 60: 1020-1022.
37. Muzina DJ, Momah C, Eudicone JM et al.Aripiprazole monotherapy in patients with rapid-cycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. Int J Clin Pract 2008; 62: 679-687.
38. Langosch JM, Drieling T, Biedermann NC et al.Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J Clin Psychopharmacol 2008; 28: 555-560.
39. Calabrese JR, Suppes T, Bowden CL et al.A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841-850.
40. Goldberg JF, Bowden CL, Calabrese JR et al.Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry 2008; 63: 125-130.
41. Walden J, Schaerer L, Schloesser S, Grunze H. An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. Bipolar Disord 2000; 2: 336-339.
42. Kemp DE, Gao K, Ganocy SJ et al.A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. J Clin Psychiatry 2009; 70: 113-121.
43. Calabrese JR, Shelton MD, Rapport DJ et al.A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005; 162: 2152-2161.
44. Baldessarini RJ, Tondo L, Floris G, Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000; 61: 13-22.
45. Hirschfeld RM. The efficacy of atypical antipsychotics in bipolar disorders. J Clin Psychiatry 2003; 64 (Suppl. 8): 15-21.
46. McIntyre R, Katzman M. The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar Disord 2003; 5 (Suppl. 2): 20-35.
47. Calabrese JR, Shelton MD, Bowden CL et al.Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001; 62 (Suppl. 14): 34-41.
48. Kukopulos A, Caliari B, Tundo A et al.Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983; 24: 249-258.
49. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138.
50. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000; 61: 804-808.
51. Schneck CD, Miklowitz DJ, Miyahara S et al.The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2008; 165: 370-377.
52. Kendall T, Glover N, Taylor C, Pilling S. Quality, bias and service user experience in healthcare: 10years of mental health guidelines at the UK National Collaborating Centre for Mental Health. Int Rev Psychiatry 2011; 23: 342-351.